PharVision Advisers’s On Holding ONON Stock Holding History

PharVision Advisers’s Portfolio ONON Stock Details ONON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,879	Closed	-$273K	–	488
2025 Q4	$273K	Buy	+5,879	New	+$253K	0.14%	333

Other funds holding ONON

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PPI

Platinum Paramount Investment Nassau $689M AUM

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

SIIL

Sinvest Investments II Ltd Nassau, New Providence $286M AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ICP

Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PharVision Advisers's ONON Position: Q1 2026 in Review

PharVision Advisers sold out of On Holding (ONON) in Q1 2026, closing a stake of 5,879 shares — an estimated $273K sold.

PharVision Advisers first reported a position in ONON in Q4 2025 and held it in 1 quarter. The position peaked at $273K in Q4 2025. 493 funds tracked by Wall St. Rank hold ONON as of Q1 2026.

PharVision Advisers reported no remaining On Holding position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,879 On Holding shares in Q1 2026, an estimated $273K.
PharVision Advisers first reported a position in On Holding in Q4 2025 and held it in 1 quarter.
PharVision Advisers's On Holding position peaked at $273K in Q4 2025.
493 funds tracked by Wall St. Rank held On Holding as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.